Literature DB >> 28111706

Chronic hepatitis C viral infection among SLE patients: the significance of coexistence.

Naim Mahroum1,2, Ashraf Hejly1,2, Shmuel Tiosano1,2, Omer Gendelman1,2, Doron Comaneshter3, Arnon D Cohen3,4, Howard Amital5,6.   

Abstract

The association between viral infection and autoimmune diseases is an established phenomenon in medicine. Hepatitis C viral infection is known to have such an association; however, its association with systemic lupus erythematosus has not been studied in a real life study driven from a large national database. The objective of this study was to investigate the association between SLE and chronic hepatitis C viral infection. Patients with SLE were compared with age- and sex-matched controls regarding the proportion chronic HCV infection. Chi-square and t tests were used for univariate analysis, and a logistic regression model was used for multivariate analysis. The study was performed utilizing the medical database of Clalit Health Services in Israel. There was a significant higher proportion of hepatitis C viral infection in SLE patients as compared to controls (1.06 and 0.39%, respectively; p < 0.001). A significant association was also observed among patients of higher socioeconomic status. In a multivariate logistic regression analysis, SLE was significantly associated with hepatitis C viral infection (OR = 2.07, 95% CI = 1.46-2.90). To conclude, Patients with SLE have a greater proportion of chronic HCV infection than matched controls.

Entities:  

Keywords:  Autoimmune disease; Hepatitis C; Infections; SLE

Mesh:

Year:  2017        PMID: 28111706     DOI: 10.1007/s12026-016-8886-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  37 in total

Review 1.  Lupus and Epstein-Barr.

Authors:  Judith A James; Julie M Robertson
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

2.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

Review 3.  The curiously suspicious: a role for Epstein-Barr virus in lupus.

Authors:  J B Harley; I T W Harley; J M Guthridge; J A James
Journal:  Lupus       Date:  2006       Impact factor: 2.911

4.  Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin.

Authors:  Gabriel M Sousa; Rodrigo C Oliveira; Mariana M Pereira; Raymundo Paraná; Maria Luiza B Sousa-Atta; Ajax M Atta
Journal:  Autoimmun Rev       Date:  2010-10-14       Impact factor: 9.754

5.  Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study.

Authors:  S Tiosano; A Farhi; A Watad; N Grysman; R Stryjer; H Amital; D Comaneshter; A D Cohen; D Amital
Journal:  Epidemiol Psychiatr Sci       Date:  2016-07-26       Impact factor: 6.892

6.  The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.

Authors:  X Liu; Y Jiao; B Cui; X Gao; J Xu; Y Zhao
Journal:  Lupus       Date:  2016-04-28       Impact factor: 2.911

Review 7.  Role of infectious agents in systemic rheumatic diseases.

Authors:  H Amital; M Govoni; R Maya; P L Meroni; B Ori; Y Shoenfeld; A Tincani; F Trotta; P Sarzi-Puttini; F Atzeni
Journal:  Clin Exp Rheumatol       Date:  2008 Jan-Feb       Impact factor: 4.473

8.  The declining risk of post-transfusion hepatitis C virus infection.

Authors:  J G Donahue; A Muñoz; P M Ness; D E Brown; D H Yawn; H A McAllister; B A Reitz; K E Nelson
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

9.  The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies.

Authors:  Yoav Arnson; Howard Amital; Serena Guiducci; Marco Matucci-Cerinic; Gabriele Valentini; Ori Barzilai; Ram Maya; Yehuda Shoenfeld
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

Review 10.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

View more
  7 in total

1.  Chronic hepatitis B viral infection among RA patients-a cross-sectional control study.

Authors:  Naim Mahroum; Abdulla Watad; Shmuel Tiosano; Ashraf Hejly; Hussein Mahagna; Roy Waknin; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Clin Rheumatol       Date:  2019-02-08       Impact factor: 2.980

2.  New onset systemic lupus erythematosus after COVID-19 infection: a case report.

Authors:  Lintu Ramachandran; Venkata Satish Dontaraju; James Troyer; Jagpal Sahota
Journal:  AME Case Rep       Date:  2022-04-25

3.  Antimalarial treatment and minimizing prednisolone are associated with lower risk of infection in SLE: a 24-month prospective cohort study.

Authors:  Ana Rita Prata; Mariana Luís; Helena Assunção; José António Pereira da Silva; Luís Sousa Inês
Journal:  Clin Rheumatol       Date:  2021-11-16       Impact factor: 2.980

4.  Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Sen Wang; Yuxin Chen; Xuejing Xu; Wei Hu; Han Shen; Junhao Chen
Journal:  Oncotarget       Date:  2017-11-01

5.  Editorial: Cutting edge in systemic lupus erythematosus.

Authors:  David P D'Cruz; Annegret Kuhn
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 6.  Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy.

Authors:  Arkadiusz Urbanowicz; Radosław Zagożdżon; Michał Ciszek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-11-15       Impact factor: 4.291

7.  The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis.

Authors:  José María Pego-Reigosa; Lindsay Nicholson; Nick Pooley; Sue Langham; Nina Embleton; Zoe Marjenberg; Volkan Barut; Barnabas Desta; Xia Wang; Julia Langham; Edward R Hammond
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.